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ABBREVIATIONS USED 
BBB: blood-brain barrier 
CM: cerebral malaria 
d#p.i.: day n post-infection 
ECM: experimental cerebral malaria 
FI: fluorescence intensity 
HCM: human cerebral malaria 
i.p.: intra-peritoneal 
i.v.: intravenously 
MF: mature (intraerythrocytic) forms 
MPS: number of merozoites per schizont 
NECM: non-experimental cerebral malaria 
o.n.: overnight 
p.i.: post-infection 
PbA: Plasmodium berghei ANKA 
PbA-GFP: constitutively green-fluorescent protein (GFP) expressing PbA 
PbA-LUCISchiz: GFP-LUCIFERASE fusion protein expressing PbA 
PbNK65: Plasmodium berghei NK65 
PbNK65-GFP: constitutively green-fluorescent protein (GFP) expressing PbNK65 
PBS: phosphate buffered saline 
pRBCs: parasitized red-blood cells 
RBCs: red-blood cells 
RT: room temperature 
WHO: World Health Organization 
WT: wild-type 
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ABSTRACT 
Malaria is an infectious disease caused by an intracellular parasite (genus Plasmodium). 
Sequestration of mature erythrocytic forms of P. falciparum is a key factor in the development of 
severe malaria-associated pathologies, namely CM. Brains of patients that died of CM show a 
preferential sequestration of the MF, and blood-smears of malaria patients at hospital admission show 
exclusively immature erythrocytic forms. Recently, it was demonstrated that in PbA-infected C576BL/6 
mice, an experimental cerebral malaria model, there is accumulation of pRBCs in the brain, as well as 
CD8
+
T cells. On the contrary, PbA-infected Balb/C mice, which don‟t develop ECM, don‟t accumulate 
these cell-populations. PbNK65-infected C57BL/6 mice also don‟t develop ECM, though they 
accumulate CD8
+
T cells in the brain, but not infected erythrocytes.  
Using these models of malaria, our main goal was to study the blood-stage dynamics and 
sequestration capabilities of both parasite strains and associate that pattern with the pathology. 
Results show that MF of both parasite strains are not seen in circulation at a certain point in infection. 
Also, this disappearance from circulation is concomitant with sequestration of PbA schizonts in the 
spleen and lungs (C57BL/6 mice), as well as in the fat tissue and liver (both hosts). In addition, we 
wanted to clarify the importance of parasite versus host in cytoadherence of pRBCs to the brain 
microvasculature. Our results suggest that the absence of PbNK65 sequestration in the brain of 
C57BL/6 mice is mainly due to differences between this parasite and PbA in its intrinsic 
cytoadherence capability. Moreover, we observed a significant difference in numbers of merozoites 
formed per schizont between PbNK65 and PbA infections, which might account for the differences in 
parasitaemia growth rates and infectivity that have been described for these strains. 
 
Keywords: malaria, Plasmodium infection, PbA, PbNK65, sequestration, cytoadherence 
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RESUMO 
A malária é uma doença infecciosa responsável por mais de 225 milhões de infecções e 781 000 
mortes por ano, a grande maioria de crianças até aos 5 anos de idade [1]. O seu impacto faz-se sentir 
não só a nível social, mas também a nível económico, sendo umas das causas da perpetuação do 
ciclo de pobreza que é vivido nos países afectados por esta doença [2].  
A malária é causada por um parasita eucariota intracelular, do género Plasmodium, transmitido 
através da picada de um mosquito do género Anopheles, que pode infectar mamíferos, répteis e 
aves. No Homem, a malária pode ser decorrente da infecção por cinco espécies diferentes: P. 
falciparum, P. vivax, P. malariae, P. ovale e P. knowlesi [3]. 
Os parasitas do género Plasmodium têm um ciclo de vida complexo que se divide entre a fase 
sexuada, no vector invertebrado, e a fase assexuada, no mamífero. A infecção inicia-se quando o 
mosquito se alimenta de sangue de um mamífero e deposita na sua derme os esporozoítos [4]. Estes 
entram na corrente sanguínea, através da qual migram até atingir o fígado, onde irão dar início à fase 
hepática da infecção, clinicamente silenciosa. Dentro dos hepatócitos, cada esporozoíto irá 
desenvolver-se, dando origem a milhares de outros parasitas – merozoítos. Estes acabarão por sair 
da célula-hospedeira em grupos de uma a duas centenas, em vesículas envoltas por membranas do 
próprio hepatócito [5, 6], chamadas merosomas. Os merosomas entram na corrente sanguínea [5] e 
tendem a acumular-se a nível dos alvéolos pulmonares [6], onde irão lisar e libertar os merozoítos. 
Estes infectam eritrócitos, dando início à fase sanguínea da infecção, a fase sintomática da malária 
[6]. Dentro dos glóbulos vermelhos, o parasita aumenta de tamanho, desenvolvendo-se da forma 
imatura, em anel, até ao trofozoíto. Nesta fase, o parasita continua a aumentar de tamanho, iniciando-
se a replicação de DNA e a produção de cristais de hemozoína, como resultado da digestão da 
hemoglobina da célula-hospedeira [7]. O momento de passagem a esquizonte dá-se quanto se inicia 
a esquizogenia. Este processo consiste num conjunto de mitoses assimétricas e assíncronas 
consecutivas que dão origem a múltiplos parasitas (merozoítos) dentro do eritrócito infectado [8]. Os 
merozoítos, aquando da lise da célula-hospedeira, libertam-se na corrente sanguínea e infectam 
outros eritrócitos, dando assim início a um novo ciclo de desenvolvimento sanguíneo. Durante a fase 
sanguínea, alguns parasitas intraeritrocíticos podem diferenciar-se em gametócitos femininos e 
masculinos, em resposta a stress ou outros factores. Os gametócitos, ao serem ingeridos por um 
mosquito numa refeição de sangue, sofrem fusão meiótica e um complexo processo de 
desenvolvimento que culmina na acumulação de esporozoítos nas glândulas salivares do mosquito. 
Estes podem ser introduzidos no hospedeiro mamífero na próxima refeição de sangue, assegurando 
assim a perpetuação da espécie [9]. 
As formas sanguíneas maturas (FSM) de P. falciparum podem ser sequestradas em vários órgãos 
[10] e esta característica está associada ao grau de severidade da doença [11]. A capacidade de 
citoaderência tem vindo a ser considerada um factor-chave no desenvolvimento de patologias 
severas associadas à malária, nomeadamente no desenvolvimento de malária cerebral (MC) [12, 13]. 
No cérebro de doentes que morreram de MC há sequestração prefencial das FSM, e os parasitas 
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encontrados nos esfregaços de sangue de pacientes que deram entrada em hospitais com malária 
severa apresentam exclusivamente formas imaturas em anel [10]. Ratinhos C57BL/6 infectados com 
P. berghei ANKA (PbA) são o modelo de MC mais usado. Foi recentemente demonstrado neste 
modelo a sequestração de eritrócitos parasitados (EP) no cérebro, assim como de células T CD8
+
, 
durante o desenvolvimento da patologia [14]. No entanto, ratinhos Balb/C infectados com o mesmo 
parasita não desenvolvem malária cerebral experimental (MCE). Foi descrito que no cérebro destes 
ratinhos não ocorre sequestração, nem de células T CD8
+
, nem de EP [14]. Curiosamente, ratinhos 
C57BL/6 infectados com P. berghei NK65 também não desenvolvem MCE nem sequestram EP, 
embora sequestrem células T CD8
+
 no cérebro [14]. Não é ainda claro se, durante a MCE, as FSM 
são as únicas que sequestram ou se estão presentes em circulação, tal como na MC humana. 
Usando os modelos murinos de malária referidos acima, o objectivo principal deste trabalho é o 
estudo da dinâmica das formas sanguíneas e a capacidade de citoaderência das duas estirpes de P. 
berghei, e a sua possível relação com sinais de doença observados nestes animais. Os nossos 
resultados mostram que, nas combinações de parasita-hospedeiro estudadas, as FSM de PbA e de 
PbNK65 dimiminuem proporcionalmente em circulação, em determinados fases da infecção in vivo e 
voltam a aumentar em proporção mais tarde na infecção.  
Para determinar se o desaparecimento de circulação das FSM de PbA é devido à sua 
sequestração em algum órgão ou à eliminação do parasita no baço, infectámos ratinhos C57BL/6 ou 
Balb/C com uma linha de PbA que expressa uma proteína de fusão, a Luciferase-GFP, apenas nas 
FSM. Em diferentes fases da infecção, e após perfusão para eliminar os parasitas circulantes, 
determinados órgãos foram extraídos (baço, fígado, pulmões e tecido adiposo) e o conteúdo em 
luciferase foi determinado por técnicas de bioimagiologia. Os nossos resultados mostram que as FSM 
de PbA sequestram a nível do baço e dos pulmões (nos ratinhos C57BL/6 infectados), assim como no 
tecido adiposo e fígado (em ambos os hospedeiros), sequestrando proporcionalmente muito mais no 
baço e no tecido adiposo. Esta sequestração é concomitante com uma diminuição da proporção 
destas formas em circulação. É de referir que os baços de ratinhos Balb/C eram mais escuros e de 
maiores dimensões do que os baços de ratinhos C57BL/6, o que pode indicar um maior conteúdo em 
hemozoína e uma maior proliferação celular. Isto sugere uma maior eliminação do parasita pelo baço 
nos ratinhos Balb/C comparativamente com os ratinhos C57BL/6. No entanto, a quantidade de 
esquizontes viáveis sequestrados é significativamente inferior nos ratinhos Balb/C do que nos 
ratinhos C57BL/6. 
Pretendíamos também esclarecer a importância relativa do parasita versus hospedeiro na 
citoaderência de EP à microvasculatura cerebral, durante o desenvolvimento de MC. 
Especificamente, pretendíamos perceber se a ausência de sequestração de EP de PbNK65 no 
cérebro de ratinhos C57BL/6 é devida à incapacidade destes EP aderirem ao endotélio activado, ou 
se poderão haver diferenças no micro-ambiente gerado no cérebro em resposta ao parasita que 
possam explicar esse fenótipo. Para isso, co-infectámos ratinhos C57BL/6 com PbNK65-GFP e PbA. 
Usando PCR-quantitativo em tempo real, medimos a expressão de GFP (e portanto a presença do 
parasita PbNK65) nos cérebros destes ratinhos, na fase final de MC. Os nossos resultados sugerem 
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que os EP por PbNK65 não são sequestrados no cérebro de ratinhos C57BL/6, devido à sua 
incapacidade intrínsica de aderir ao endotélio activado. 
Este projecto pretendia clarificar a dinâmica das formas circulantes e a capacidade de 
citoaderência de duas estirpes de P. berghei, e a forma como estes padrões se podem correlacionar 
com a patologia. Os resultados não são conclusivos e mais experiências têm de ser realizadas para 
elucidar este assunto. No entanto, consideramos que indiciam diferenças entre os mecanismos de 
sequestração no cérebro em relação a outros órgãos, de PbA, assim como de PbNK65. Os nossos 
resultados também sugerem que existem diferenças intrínsecas ao parasita na capacidade de 
citoaderência de EP por PbA versus EP por PbNK65 à microvasculatura cerebral. Além disto, 
observámos uma diferença significativa no número de merozoítos formados por cada esquizonte, 
entre a infecção sanguínea por PbA e por PbNK65. Sugerimos que este facto pode estar na origem 
das diferenças já descritas [15] entre as duas estirpes de P. berghei no que diz respeito à taxa de 
crescimento de parasitémia e infecciosidade. 
Palavras-chave: malária, infecção com Plasmodium, PbA, PbNK65, citoaderência, sequestração 
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INTRODUCTION 
Malaria 
According to the WHO, malaria alone is responsible for more than 225 million infections and close 
to 781 000 deaths each year, the vast majority children up to 5 years of age. The number of deaths, if 
co-infection with AIDS and/or tuberculosis is accounted for, may be close to 3 million, each year [1]. 
Despite the fact that malaria has accompanied humans since the dawn of civilization – the first records 
dating back to 2600 BCE, in China and Egypt [16] – it is still one of the most deadly infectious 
diseases in the world  [1]. Moreover malaria is not only a disease with a severe social burden, but also 
with a serious impact on the economy. In some countries, it accounts for up to 40% of all public health 
expenditures. If we consider that up to 20% of people who survive the more severe cases of the 
disease develop sequelae (mostly neurological), we must also account for decreasing productivity, 
which perpetuates the cycle of poverty [2]. 
Malaria is an infectious disease caused by an eukaryotic parasite from the genus Plasmodium, 
which can infect birds, reptiles and mammals [17], though each Plasmodium species infects a limited 
number of closely related vertebrate species [3]. Five species can cause malaria in humans: P. 
falciparum, P. vivax, P. ovale, P. malariae and P. knowlesi (a macaque monkeys‟ parasite that has 
been recently described by the WHO to infect and cause the disease in humans). P. falciparum and P. 
vivax are responsible for the vast majority of clinical cases, the former being responsible for the most 
severe forms of malaria, which include cerebral malaria (CM) and malaria-associated respiratory 
distress syndrome (MAARDS). Malaria is transmitted to the vertebrate host by the bite of infected 
female Anopheles mosquitoes, which are part of the most ubiquitous and abundant arthropod genera 
existent [3]. 
Plasmodium life cycle 
Plasmodium parasites have a complex life-cycle, consisting of the asexual stages, in the vertebrate 
host, and the sexual stages that take place in the mosquito vector (Figure 1). 
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Human malaria infection is initiated when infected female Anopheles mosquitoes take a blood-meal 
and deposit sporozoites in the dermal tissue of the human host [4] (Figure 1). Sporozoites then travel 
through the circulation until they reach the liver. Here they go through an obligatory and clinically silent 
developmental stage that can last up to 16 days, depending on the Plasmodium species (reviewed in 
[18]). In the liver, each sporozoite traverses a few hepatocytes before developing and replicating in a 
final one [19], originating thousands of merozoites. The parasite‟s membrane will collapse, causing the 
merozoites to be released in the cytosol of the host cell. They will then form aggregates of a couple 
hundred merozoites that remain enclosed in membranes of host-cell origin [5, 6]. These structures – 
merosomes – bud out from the infected hepatocytes, enter the bloodstream [5] and tend to 
accumulate in the lungs microvasculature [6]. Then they will break up and release merozoites into the 
bloodstream, beginning the erythrocytic/blood-stage, which is the symptomatic stage of the infection 
[6]. 
The erythrocytic stage (Figure 1, Figure 2) begins when a merozoite adheres to and infects a red-
blood cell (RBC). Parasite entry into erythrocytes is a complex and dynamic process not fully 
understood. It likely requires proteins residing on the invasive parasite surface, called merozoite 
surface proteins, as well as other proteins associated with secretory organelles directed by the 
parasite toward the junction of invasion (reviewed in [20] for P. falciparum). By the end of the 
recognition and ligation process, the invagination of the erythrocyte membrane leads to the 
engulfment of the parasite and the establishment of the intracellular ring-stage parasite that is 
characteristically surrounded by a vacuolar membrane [21].  
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The ring-form will grow in size, giving rise to a trophozoite. By this stage, the parasite has 
exhausted the host-cell‟s metabolites. Haeme is produced by the trophozoite as a toxic product of 
haemoglobin digestion and is converted into haemozoin, a pigmented crystal that is characteristic of 
Plasmodium blood-stage infection (reviewed in [7]). Later in this stage, the parasite will continue to 
grow in size (as well as haemozoin content), starting DNA replication inside its host  [7, 8]. Entrance in 
the schizont stage is defined by schizogeny, i.e. the asymmetric and asynchronous mitotic division 
that leads to the formation of multiple parasites (merozoites) inside the host RBC  [7, 8, 22]. 
Merozoites will eventually cause the host-cell lysis, being released into the bloodstream. They will 
quickly invade and infect a new RBC, thus beginning a new cycle of intraerythrocytic development 
(Figure 1, Figure 2).  
The number of merozoites formed per schizont can be up to 32 and varies between Plasmodium 
species (reviewed in [23]). This multiplication rate is related to the increase in parasite biomass that 
occurs in each cycle, which is known to be related with disease severity in human patients  [24]. 
Some parasites inside RBCs can differentiate (in response to stress or other cues) into male or 
female gametocytes. Upon ingestion by a feeding female mosquito, they can fuse, undergo complex 
sexual development and form infective sporozoites that accumulate in the salivary glands of the 
mosquito and can be introduced into the human host at the next blood meal, thereby ensuring the 
perpetuation of the species (reviewed in [9]). 
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The typical pattern of malaria symptoms and signs – which include fever, nausea and headache, 
sometimes accompanied by diarrhoea and vomiting – is associated with the release of merozoites by 
erythrocytes. The time pattern of these signs depends on the length of the erythrocytic cycle (24, 48 or 
72 hours, depending on the Plasmodium species) and also on its relative synchronization. The fever 
cycles are due to the synchronous development of Plasmodium inside RBCs, their rupture and the 
coordinated mass-release of merozoites and toxins into the bloodstream (as reviewed in [23]). These 
symptoms/signs may remain relatively mild, or progress to severe attacks (reviewed in [25]). If left 
untreated, P. falciparum malaria may evolve to severe and often fatal manifestations, such as malaria-
associated acute respiratory distress syndrome (MAARDS) or cerebral malaria (CM), partly due to 
sequestration that is a hallmark of this species. 
Sequestration and human cerebral malaria 
Cerebral malaria (CM) is a severe form of P. falciparum infection that affects 575 000 children a 
year in Africa with 10-40% lethality (reviewed in [1]). CM is characterized by cerebral complications, 
such as neuronal damage and coma, often accompanied by fever, convulsions, seizures, metabolic 
acidosis and hypoglycaemia. A significant proportion of survivors have permanent neurological 
complications including cognitive and speech disorders, motor abnormalities and cortical blindness 
(reviewed in [25]).  
Although it has been the subject of a number of studies throughout the XX
th
 century [26], the 
cascade of events leading to CM is still poorly understood [27, 28]. 
One of the first scientific descriptions of cerebral malaria dates back to 1717 and was written by 
Giovanni Maria Lancisi. Though his “De noxiis paludum effluviis, eorumque remediis” is focused in the 
possible means of transmission of malaria [29], he was one of the first to describe “the graphite 
pigmentation of a postmortem (…) brain”, i.e. the presence of haemozoin (the malarial pigment present 
in the blood-stage parasites) in the brains of patients that died of CM. 
Nowadays, there are two complementary hypotheses that attempt to explain the causes of human 
cerebral malaria (HCM): the “mechanical hypothesis” (reviewed in [12]) and the “inflammation 
hypothesis” (reviewed in [13]).  
According to the “mechanical hypothesis”, the mechanical pressure or blockage caused by the 
accumulation of pRBCs, in the brain‟s microvasculature (due mainly to their decreased deformability), 
causes a decreased blood-flow in this organ, leading to the blood-brain barrier (BBB) breakdown, 
which in turn will cause haemorrhages, decreased oxygenation and removal of waste products. 
On the other hand, malaria infection causes a generalized inflammatory process directed at 
controlling the infection. The inflammation process includes the activation of the innate immune 
response, the production of pro-inflammatory cytokines and the activation of T cells, leading to an up-
regulation of adhesion molecules in circulating cells and in the endothelial cells, as well as secretion of 
chemokines important for leukocyte traffic. According to the “inflammation hypothesis”, as a 
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consequence of this cascade, sequestration of pRBC, platelets and activated immune cells (including 
CD8
+
 T cells) would occur in the microvasculature of the host, accounting for the BBB breakdown, 
haemorrhages and all the neurological disturbances commonly associated with HCM. 
Therefore, both hypotheses consider brain sequestration/accumulation of pRBCs as a key factor in 
the development of HCM. Though both hypotheses are unlikely to mutually exclude each other, the 
“inflammation hypothesis” has gained more and more evidences to support it in the last years 
(reviewed in [30] and [31]).  
Thus, it has become clear that sequestration in the brain of the later erythrocytic stages (as well as 
of leukocytes) is a major process in the development of HCM and that it seems to be concomitant with 
their absence from the circulating blood [10]. This is in accordance with the exclusivity of ring-forms in 
the blood-smears of P. falciparum infected people appearing in hospitals. In other human non- P. 
falciparum malarias, all stages can be present in the circulating blood (as reviewed in [32]). 
It is thought that this capability to sequester, which contributes greatly to the virulence of P. 
falciparum, is also a mechanism that favours the development of the parasite by protecting it from the 
action of the spleen, where the mature erythrocytic stages of P. falciparum would be more easily 
detected and eliminated by the macrophages (reviewed in [11]). 
The mechanisms of pRBCs sequestration remain unclear. However, ultrastructural studies have 
suggested that adherence of parasitized erythrocytes to the vascular endothelium occurs by means of 
excrescences on the infected erythrocyte membrane that have been called knobs [11]. Others have 
also pointed out that mature-stage pRBCs express new surface antigens and are significantly less 
deformable than ring-stage pRBCs (as reviewed in [32]), which may also be a consequence of the 
presence of knobs. These are cup-shaped structures that underlie protrusions of the erythrocyte 
membrane, the main component of which is the knob-associated histidine-rich protein (KAHRP), 
essential for the sequestration phenotype [33]. 
As the parasite develops inside the erythrocyte, several parasite-encoded proteins become 
associated with its host-cell cytoskeleton or are inserted into the host cell membrane, via Maurer‟s 
clefts. These consist of a convoluted set of membranes, morphologically similar to the Golgi 
apparatus, located underneath the pRBC membrane, and appear to be involved in trafficking and 
sorting of proteins destined to be delivered to the erythrocyte‟s cytosol and membrane (reviewed in 
[34]). Some proteins, such as the widely studied P. falciparum erythrocyte membrane protein 1 
(PfEMP1) or protein 3 (PfEMP3), are transported through these clefts in association with knob 
proteins, like KAHRP, and are necessary to promote cytoadherence and sequestration of pRBCs 
within the blood-vessels [34]. Proteins associated with Maurer‟s clefts-like and knob-like structures 
have been identified in other Plasmodium species – such as P. berghei and P. chabaudi (both 
infecting rodents) – suggesting that these proteins are conserved among malaria species [35, 36]. 
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Murine models of cerebral malaria 
Clinical studies of severe human malaria are limited in terms of the amount of information we can 
retrieve from them. Though some aspects of the HCM disorder – vascular obstruction and 
inflammation leading to tissue damage and disordered neurotransmission – are now clear, the exact 
sequence of events leading to the neurological damage typical of HCM remains unknown. Further 
knowledge on the different risks and causative factors can only be obtained through a more direct 
experimental approach, which is clearly unethical in humans. Experimental animal models are 
therefore required to help us comprehend the processes that lead to malaria associated pathologies 
(as discussed in [25, 37]). 
Different models can be used to mimic different aspects of the disease, i.e. different parasite 
strains and mouse strains can be combined to study the many manifestations of malaria, such as 
HCM. Despite recent articles questioning the conclusions that can be drawn from studies in animal 
models of experimental cerebral malaria (ECM) [38], it is clear the utility of such models in 
understanding the mechanisms underlying this pathology [25, 37, 39]. Though such mechanisms must 
be further validated – not only using more than one model of the disease but also in human clinical 
studies carried out in the field – it is getting more and more obvious the phylogenetic similarities 
between all the Plasmodium species [40, 41] and also the resemblance between HCM and 
experimental cerebral malaria (ECM) [28]. 
Infection of C57BL/6 mice with P. berghei ANKA (PbA) is the most commonly used model to study 
ECM [42]. One of the most cited critics against this model of HCM is that it doesn‟t replicate the 
human syndrome and therefore conclusions may not be confidently drawn from mechanisms of CM 
observed in murines [38]. Though parasite sequestration has clearly been shown for P. falciparum and 
is considered essential in the development of HCM (as stated above), it was not demonstrated in P. 
berghei until recently [14]. This new fact shows that the murine CM model shares key features with 
HCM and that it is relevant to its study. 
The Plasmodium berghei parasite 
Plasmodium berghei is a species of Plasmodium capable of infecting rodents that is widely used in 
experimental studies of malaria.  
Plasmodium berghei ANKA has been long used to induce ECM in C57BL/6 mice and to study this 
pathology experimentally. Eighty to one hundred percent of these infected mice die of ECM at day 5 to 
8 after pRBC injection, with relatively low numbers of pRBCs in the blood. On the contrary, close to 
100% of Balb/C mice infected with this parasite strain don‟t develop ECM, but instead go on to 
develop high levels of pRBCs in the blood and die from anaemia about 3 weeks after blood-stage 
infection. The latter is the most commonly used non-ECM (NECM) control. 
Plasmodium berghei NK65 [43]-infected C57BL/6 mice– though less widely used – also don‟t 
develop ECM, but instead die with anaemia and hyperparasitaemia, 2 to 3 weeks after blood-stage 
infection. 
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Sequestration in ECM – new insights from murine models 
As previously stated, sequestration of pRBCs in the cerebral microvasculature in P. falciparum-
infected people has been implicated as the major process responsible for the development of HCM. 
However, the observation of this phenomenon in non-CM cases suggested that other factors are 
involved [10]. The first evidence of leukocyte involvement in HCM pathogenesis came from the 
observation that individuals suffering from thymic abnormalities were protected from severe malaria 
[44]. Moreover, leukocytes were detected in the brains of patients that had died of HCM. 
Similarly to what happens in humans, in the murine model there is accumulation of CD8
+
 T cells in 
the brains of mice at the onset of ECM. This population of cells was shown to be necessary for the 
development of this disorder, since their depletion in the 24 hours preceding ECM prevents its 
development [45]. However, accumulation of CD8
+
 T cells alone does not account for the development 
of ECM, since there is also accumulation of these cells in the brains of some non-ECM (NECM) mice 
models – namely the P. berghei NK65 infected C57BL/6 mice model [14]. 
Recently, it has been clearly shown that there is also accumulation of P. berghei infected cells in 
the brains of ECM mice (but not NECM models) just before they start to show neurological signs, and 
this process was shown to be essential for the development of ECM [14]. Not only does depletion of 
CD8
+
 T cells protect mice from ECM, but also leads to a significant decrease in the pRBC burden in 
the brain of these mice [14]. Also, if the mice are treated with an anti-malarial drug and the parasite is 
cleared from circulation, in the 24 hours preceding the onset of ECM, there is no reduction of CD8
+
 T 
cells content in the brain, but the mice are protected [14]. This clearly shows that parasite 
sequestration in the brain is crucial for the development of ECM as of HCM.  
However, it is not known whether only the mature erythrocytic forms sequester and whether they 
disappear from circulation as a result of their sequestration in the brain and/or other organs, as in 
human malaria. 
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AIMS 
The main goal of this project was to assess the capability and dynamics of P. berghei pRBCs 
sequestration in different malaria models (ECM versus NECM), ex vivo and in vivo.  
Whether parasite-features or host-features are more relevant in the development of ECM has 
always been subject of discussion [46]. Sequestration of pRBCs in the brain is dependent on many 
factors – including the existence of appropriate parasite ligands in the surface of pRBCs, receptors 
expressed in the surface of activated endothelial cells, among others – which have to come together 
inside a relatively small time window. Some argue that the parasite is more preponderant, others that 
the inflammation process has more influence on the pathogenesis (see above). The sequestration 
process is essential in the development of ECM and cytoadherence of pRBCs seems to be a key step 
in the sequence of events leading to the pathology. Using a malaria murine model, namely PbNK65-
infected C57BL/6 mice, we wanted to assess whether absence of cytoadherence of pRBCs during 
Plasmodium blood-stage infection may be caused by the lack of an intrinsic factor of the parasite or 
whether differences in the brain microenvironment generated by the host‟s immune response may 
play a role. 
Moreover, though sequestration of pRBCs has been established as essential in the development of 
severe malaria, it is not yet known which erythrocytic forms actually sequester, or if there is differential 
sequestration. In HCM, the mature forms sequester preferentially, so we wanted to determine if the 
same occurs in ECM. Therefore, we studied the dynamics of mature intraerythrocytic stages of PbA, 
and whether or not they are seen in circulating blood before or during the onset of ECM, as opposed 
to NECM. Additionally, we used an in vivo imaging approach to assess if PbA mature schizonts 
preferentially sequester in certain organs in C57BL/6 or Balb/C mice. 
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MATERIALS AND METHODS 
Parasites 
The following Plasmodium berghei ANKA parasites were used: P. berghei ANKA “wild-type” line 
(PbA); P. berghei ANKA line expressing GFP under the control of an housekeeping gene (line GFPCON 
259cl2; PbA-GFP) [47]; and a parasite line expressing a Luciferase-GFP fusion protein under the 
control of ama-1 which is expressed only in the schizonts, during blood-stage infection (line 354cl4; 
PbA-LUCISchiz) [48]. The following Plasmodium berghei NK65 parasites were used: “wild-type” line 
(PbNK65) and a parasite line expressing GFP under the control of an housekeeping gene (PbNK65-
GFP). 
P. berghei-infected RBCs are kept in Alsever‟s solution (at 10
7
 pRBCs/ml), stored at -80ºC and 
defrost immediately before infection. 
Mice 
All experiments were carried out in male C57BL/6 or Balb/C mice (from Charles River 
Laboratories), aged 6 to 10 weeks. Animals used for blood passage (see below) were C57BL/6, older 
than 6 weeks. In each experiment, all animals were matched by age. 
All mice were housed at the animal facilities at the Instituto de Medicina Molecular, according to the 
guidelines of the Animal Care Committee of the IMM. All protocols involving live animals were 
approved by the aforementioned Committee. 
Induction and progression of blood-stage infections 
All experimental mice were infected intraperitoneally (i.p.) with either 10
6
 fresh pRBCs collected 
from another mouse, which was infected with a frozen vial (blood passage), or with 2x10
6
 frozen 
pRBCs (infection with frozen vial). 
Concerning the in vivo cytoadherence assays, one experimental group was subjected to mixed 
infections, i.e., was infected i.p. with 10
6
 fresh pRBCs of each parasite (PbA and PbNK65-GFP). 
Parasitaemia (number of pRBCs / total number of RBCs x 100) was assessed by microscopic 
evaluation of Giemsa stained tail-blood smears [4], by counting at least 1000 RBCs. Alternatively, 
when GFP-expressing parasites were used, parasitaemia was evaluated by flow-cytometry. Briefly, a 
drop of tail-blood was recovered into a solution of 1% fetal bovine serum (FBS) in PBS 1x, and kept at 
4ºC until analyzed in a flow cytometer (see below). 
Assessment of experimental cerebral malaria onset and progression 
In our hands, PbA-infected C57BL/6 mice develop experimental cerebral malaria (ECM) between 
d5 and d8p.i. Observable signs of the pathology in these mice include: loss of aggressiveness, 
decrease in activity and body-temperature, loss of strength in both the posterior and anterior limbs, 
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loss of short-term memory, loss of curiosity, alterations in posture and fur maintenance/hygiene habits, 
etc. 
The neurocognitive state of experimental mice was assessed using a quantitative analytic scale 
described by Carrol et al. [49]. The “Rapid Murine Behaviour and Coma Scale” (RMBCS) consists of a 
list of ten parameters to which a numerical value is attributed. Parameters tested include gait, 
curiosity, limb strength, toe pinch and touch escape, and each one can be scored as 0, 1 or 2, adding 
up to an overall score of 20. The higher the value, the healthier the mouse is, and vice-versa. We 
considered mice to be in ECM, when their overall score was below 13.  
In vitro synchronization and purification of Plasmodium berghei late intraerythrocytic 
stages 
Plasmodium berghei is one of the few mammalian parasites whose schizonts don‟t rupture 
spontaneously in vitro. This feature is the rational support behind the parasite synchronization 
protocol[50] described below, resulting that after overnight (o.n.) incubation most of the pRBCs are 
synchronized in the more mature stages [51]. 
Briefly, infected mice were sacrificed by CO2 inhalation and the blood collected by cardiac 
puncture, into 30 ml of PBS 1x. Blood was then centrifuged at 650 g (without brake), for 10 minutes at 
4ºC. The supernatant was discarded and the pellet carefully resuspended in 50 ml of the culture 
medium solution (RPMI 1640, supplemented with 25% FBS, 2mM L-Glutamine, penicillin-streptomycin 
at 50µg/ml, 1% HEPES, 1% non-essential amino-acids), before being divided by two 25 cm
3
 culture 
flasks. Flasks were gasified with a mixture of 5% CO2, 90% N2 and 5% O2, for 1 minute each, sealed 
and incubated for 12-16 hours, in the dark, at 37ºC, at low rotational speed.  These mature 
synchronized pRBCs were analysed by flow cytometry and used in the design of gates for GFP-
positive sub-populations (see below). In addition, a drop of each these suspensions was placed on a 
microscope slide, allowed to dry before fixating with 4% PFA and staining with a 1:200 DAPI solution 
(stock solution at 1 mg/ml) for 1 hour. Slides were washed with PBS 1x and mounted with Fluormount-
G™ (SouthernBiotech, U.K.).  
For the ex vivo cytoadherence assays, after the o.n. incubation, mature pRBCs were isolated by a 
density gradient. Briefly, the RBCs suspensions were carefully resuspended, pipetted on top of 10 ml 
of a 65% Nicodenz solution and then centrifuged at 550 g, for 30 minutes at 21ºC (without brake). 
Most of the upper layer was discarded and the interface between the upper layer and the bottom layer 
was pipetted into a 50 ml Falcon tube and the volume added up to 40 ml of PBS 1x. This cell 
suspension was centrifuged at 580 g, for 8 minutes (without brake) and the pellet was resuspended in 
500 µl of PBS 1x. RBCs were counted in a Neubauer chamber, and a final solution of 10
8
 pRBCs / ml 
was prepared. 
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Quantification of Plasmodium berghei pRBCs by flow-cytometry 
For the experiments regarding the in vivo parasite dynamics, constitutively expressing GFP 
parasites were used to infect either C57BL/6 or Balb/C mice. Both parasites used have GFP under the 
promoter of an housekeeping gene (elongation factor 1 alpha - ef1α), though PbA-GFP has three 
copies of the GFP construct integrated, while the PbNK65-GFP parasite has only one copy. 
Parasitaemia was determined by flow cytometry using a LSRFortessa™ cell analyser (BD 
Biosciences, USA) and the BD FACSDiva™ software. The GFP-fluorescence intensity of different 
intraerythrocytic stages was analyzed by gating the GFP-positive RBCs in blood from infected mice, 
after defining the gates for RBCs based on their forward-scatter (FSC) and side-scatter (SSC) signals. 
The excitation of cells was performed with an argon ion laser at a wavelength of 488 nm and emission 
of the green fluorescence was detected using a band pass filter of 530/30 nm. Analysis of flow 
cytometry data was done with FlowJo™ software v6.4.7 or v9.3.2 (TreeStar Inc., USA).  
According to Frank-Fayard et al. [52], the asexual intraerythrocytic stages show a linear correlation 
between developmental stage of the parasite and fluorescence intensity. In their study, late schizonts 
have 13 to 14 times the fluorescence intensity of ring-forms, which is related to the haploidy of late 
schizonts, i.e., the number of merozoites existent per late schizont. 
In the present work, we used the o.n. synchronized parasites to confirm these values. The number 
of merozoites per schizont (MPS) was assessed for each combination of parasite-host on DAPI-
stained thin blood smears from in vitro synchronized pRBCs cultures. MPS values were used to define 
the gates on flow cytometry for the early pRBCs (mononucleated) and mature parasites 
(multinucleated) populations. The gates were then applied to the in vivo parasite dynamics. 
Quantification of brain parasite load by qRT-PCR 
Brains were collected after intracardiac perfusion (20 ml of PBS), snap frozen in liquid nitrogen and 
stored until RNA extraction. Organs were mechanically homogenised in 2 ml of denaturing solution (4 
M guanidine thiocyanate; 25 mM sodium citrate pH 7; 0,5% N-Lauroyllsarcosine; and 0,7% of freshly 
added β-mercaptoethanol, in Diethylpyrocarbonate (DEPC)-treated  water). RNA was extracted using 
a Qiagen RNeasy minikit, according to the manufacturer‟s instructions.  
The synthesis of the first-strand cDNA from the RNA templates was carried out using the AMV 
Reverse Trancriptase Kit (Roche). The amplification program was as follows:  25ºC (10 min), 55ºC (30 
min) and 85ºC (5 min). 
cDNA present in the samples was then amplified by qRT-PCR using the Finnzymes F-410XL 
DyNAmo™ HS SYBR® kit on an ABI Prism 7500 Fast Real-Time PCR System (Applied Biosystems), 
configured with the instrument‟s standard ramp speed and the following amplification program:  50ºC 
(2  min)  and 95ºC (10 min),  followed by 50 cycles of 95ºC (15 sec) and 60ºC (1 min), and one cycle 
of 95ºC (15 sec), 60ºC (1 min), 95ºC (30  sec) and 60ºC (15  sec). The relative expression of P. 
berghei‟s 18s or gfp genes (targeted with primers 5‟-AAG CAT TAA ATA AAG CGA ATA CAT CCT 
 
19 
TAC-3‟, 5‟-GGA GAT TGG TTT TGA CGT TTA TGT G-3‟ and 5‟-GTC AGT GGA GAG GGT GAA GG-
3‟, 5‟-ACT TCA GCA CGT GTC TTG TAG TTC-3‟, respectively) was performed using the mouse 
housekeeping gene hypoxanthine guanine phosphoribosyl transferase (hprt) as an endogenous 
reference (targeted with primers 5‟-TTT GCT GAC CTG CTG GAT TAC-3'; 5‟-CAA GAC ATT CTT 
TCC AGT TAA AGT TG-3‟).  
Parasite load was calculated as the relative amount of P. berghei 18s cDNA copies against hprt 
cDNA copies or the relative amount of gfp cDNA copies against hprt cDNA copies. 
Determination of parasite load by in vivo imaging techniques 
C57BL/6 and Balb/C mice were infected with a PbA line expressing a GFP-Luciferase fusion 
protein, under the control of the promoter of ama-1 (PbA-LUCISCHI), which is expressed only in mature 
schizonts. The load of circulating schizonts was evaluated at the time of sacrifice, by flow cytometry 
analysis of GFP (see above), and parasitaemia was calculated by manually counting on Giemsa-
stained tail-blood smears (see above). 
Five mice per group were sacrificed per time point, in a total of 3 time-points. One mouse of each 
group (ECM and NECM) was injected i.p. with a solution of D-Luciferin (Promega Luciferase Assay 
System). After 7 minutes, both mice were sacrificed and perfused with 20ml of PBS before organ 
extraction. Organs extracted were: liver, lungs, spleen and fat-tissue. Samples were placed in a Petri 
dish and immediately analyzed using an IVIS Lumina® imaging system (Caliper LifeSciences, Inc.; 
USA), with 5 min exposure. To calculate relative luminescence units (R.L.U.), total luminescence 
counts were divided by the area (in pixels) of each organ. 
Ex vivo cytoadherence assays 
For the ex vivo assessment of cytoadherence capabilities of PbNK65 to brain blood-vessels, the 
Woodruff-Stamper assay [53] was used and optimized similarly to what is described by Neres et al. 
[54]. 
Brains of naïve or infected mice were collected, after intracardiac perfusion with 20 ml of PBS 1x, 
and snap frozen in liquid nitrogen. They were then preserved at -80ºC, until cut with a cryostat in 7 µm 
thick sections (Leica CM 3050S, Leica Microsystems, Germany). Sections were then allowed to dry 
completely at RT before being used. Each section was delimited with a Dako Pen (Dako, Denmark). 
Sections were then washed with PBS 1x, for 5 minutes. Sections were then incubated with 50 µl of a 
10
8
 pRBCs/ml mature schizont-enriched cell suspension, at 37ºC, for 1 hour at low rotational speed, in 
an opaque humid-chamber. Slides were washed by inversion in a 50 ml Falcon tube with cold PBS 1x, 
for 5 minutes, and this step was repeated once. Sections were then incubated with paraformaldeyde 
(PFA) at 2%, for 10 minutes, at RT, and washed with PBS, before incubating with an anti-GFP 
antibody solution, for 1 hour. Slides were washed and incubated with a DAPI solution for 2 minutes. 
Slides were again washed by inversion in a 50 ml Falcon tube with PBS 1x, before mounting with 
Fluormount-G™ (SouthernBiotech, U.K.).  
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Sections were analysed with a Leica DM5000 B widefield fluorescence microscope (Leica 
Microsystems, Germany), using 400x magnification, and a monochrome CCD camera for fluorescence 
image acquisition. For GFP and DAPI detection, excitation of the samples was performed with a laser 
at a wavelength range of 430-510 nm and 320-400 nm, and emission was detected using a filter of 
475-575 nm and 430-510 nm, respectively. 
Violet Cresyl staining for analysis of infected brain sections 
PbA-infected C57BL/6 mice were sacrificed, by CO2 inhalation; at ECM score below 8 around day 
5 to day 8 p.i. PbNK65-infected C57BL/6 mice were sacrificed at d8p.i. with similar parasitaemias. 
After intracardiac perfusion with 50 ml of PBS 1x, followed by perfusion with 50 ml of a 4% 
paraformaldehyde (PFA) solution, brains were collected and kept for 24 hours in 4% PFA, at 4ºC. The 
4% PFA solution was replaced by a 30% glucose solution and kept at 4ºC until cryostat sectioning 
(Cryostat LEICA CM 3050S, Leica Microsystems, USA).  
Histological staining was performed on 40 µm thick coronal brain sections, allowed to dry 
completely before storing at 4ºC until staining.  
Before staining, sections were hydrated, for 2 minutes, in dH2O and for another minute in another 
dH2O-filled tank. Sections were then stained for 5 minutes in a Violet Cresyl solution, washed for one 
minute with dH2O and passed on a 50% ethanol solution for one minute. Slides were then dipped in an 
ethanol and glacial acid solution at 70%, for 1 minute, before being dehydrated in 95% and 100% 
ethanol solutions, as well as xylene (for 1 minute in each tank). Slides were then mounted with DPX 
(Sigma Aldrich, U.K.), allowed to dry and kept in the dark until observation. 
Analysis of stained sections was done using a Leica DMR upright widefield microscope (Leica 
Microsystems, Germany) and all photographs were acquired with a Leica DC500 colour camera and 
Photoshop CS2 (Adobe Systems Incorporated, USA). 
Statistical analysis 
Statistical analysis was performed using the non-parametric Mann-Whitney‟s test, on GraphPad 
Prism Software v5.04 (GraphPad Software, USA).  
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RESULTS 
Dynamics of circulating blood-stage forms of PbA and PbNK65 
As stated above, in P. falciparum malaria the mature forms are absent from circulation and present 
in the brains of patients suffering from HCM [10] and other organs. In the case of ECM, it has been 
demonstrated that PbA accumulates in the brains of C57BL/6 mice during the pathology [14], but 
whether this correlates with a decrease in circulation of schizonts and/or trophozoites in circulation is 
yet to be shown.  
To follow these populations throughout infection and compare their dynamics in ECM and NECM 
models, a flow-cytometry based assay was used. For this, PbA and PbNK65 lines of GFP-expressing 
parasites were injected in C57BL/6 and/or Balb/C mice and tail-blood was collected at several time-
points for analysis (see above). 
Validation of flow-cytometry gating strategy 
Franke-Fayard et al. [52] have shown that PbA schizonts (in Swiss mice) displayed fluorescence-
intensity (FI) values of 13 to 14 times the FI of ring-forms, which correlates with the number of 
merozoites found per mature schizont (MPS).  
We started by analysing samples after in vitro synchronization by flow cytometry. This allowed a 
clear distinction between the populations expressing low levels of GFP and high levels of GFP (peak A 
and peak B, respectively, in Figure 3. A). Considering that the vast majority of pRBCs found in the 
Giemsa-stained smears obtained for the same samples were maturing schizonts (as expected), it is 
valid to associate this population with the peak B. Late ring-forms, though much less represented, 
were also present in these smears. Therefore, we could correlate peak A with these asexual forms. 
We then used the fluorescence intensity values obtained to calculate the ratio between the FI of B and 
A, as a measure of the haploidy of mature schizonts, i.e. the number of MPS. To validate this 
assumption, the number of MPS for each combination of parasite-host was calculated (Figure 3. B), 
by manual counting on DAPI-stained blood smears after in vitro synchronization [51]. No statistically 
significant difference was found between the numbers of MPS measured by both approaches (Figure 
3. B) which validated the flow cytometry approach. Interestingly, MPS values were similar for PbA-
infected blood after o.n. incubation, from both Balb/C and C57BL/6 mice. However, for the 
PbNK65+C57BL/6 combination this value was significantly reduced (Figure 3. B). 
By extending peaks A and B, we designed gates G1 and G3, respectively (Figure 3. C). Gate G2 
was designed to include all intermediate events (Figure 3. C). G1 includes ring-forms and some early 
trophozoites; G2 includes trophozoites; and G3 includes mainly mature schizonts, but also late 
trophozoites, immature schizonts and possibly male gametes (that express GFP at similar FI as 
mature schizonts) [52]. The non-gated population with the highest FI included female gametocytes, 
expressing at least 30 times more GFP than the ring-forms (consistent with data previously published 
[52]). Since only asexual erythrocytic forms were studied in this project, this population was discarded 
from further analysis. As was already mentioned, the rationale behind this gating strategy is that there 
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is a linear correlation between development and green-fluorescence intensity [52], meaning that the 
higher the amount of parasite-DNA present in the cell, the higher the expression of GFP.  
 
The gates, designed for the analysis of samples after o.n. incubation, were then applied to the 
study of in vivo dynamics of asexual circulating parasites, which was our main objective in these 
experiments (referred thereafter as “dynamics”). It should be noted that the GFP-expressing PbNK65 
line used in this study only has 1 copy of GFP, so it was necessary to use different voltage settings in 
the acquisition of RBCs infected with this parasite, to be able to separate the GFP-positive from the 
GFP-negative populations. This also meant designing different gates, which were submitted to the 
same validation process. 
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In vivo dynamics of asexual circulating forms of PbA and PbNK65 
Three independent experiments were performed to analyse in vivo dynamics of PbA in the models 
already described (two for the PbNK6 model). Mice were injected i.p. with 10
6
 pRBCs of GFP-
expressing parasites. Blood was then collected (starting on d4 p.i.) at several time-points per day, for 
flow-cytometry analysis. Gating strategy is described above.  
Parasitaemia in early infection was similar for all three combinations of parasite-host (Figure 4). 
However, though parasitaemia in PbA infection quickly increased from d4p.i. (in both hosts), 
parasitaemia in PbNK65 infection increased much more slowly. In late infection, the difference in 
parasitaemia between PbA and PbNK65 infections was more evident, with PbNK65 infections at 1/3 
the values of parasitaemia of the PbA infections (see legend of Figure 5. B). 
 
It was observed a striking synchronization in all mice from the same experimental group for the 
entire duration of the experiments (Figure 5. A).  
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In both hosts, the proportion of PbA‟s G1 seemed to oscillate cyclically (Figure 5. B). Interestingly, 
in one of the experiments (Annex A: Figure 1. B), this cycle seemed to be inverted comparing PbA in 
both hosts, already on d4p.i. In the case of PbNK65, the oscillation in the proportion of G1 versus G3 
is not as pronounced, but it is also present (Figure 5. B).  
In the ECM model, PbA‟s G3 seem to decrease in the circulating blood concomitantly with the 
onset of the pathology (Figure 6. B). However, in the Balb/C host, in spite of this mice not developing 
ECM, the G3 population seems to also decrease with time (Figure 6. A). PbNK65‟s G3 are seen in 
lower percentages in the circulation, than in the PbA infection. From d6 p.i. onwards the mature forms 
(G3) were seen in very small proportions in circulation in all models (Figure A. A) and were seen 
again on the blood at d14 and d15 p.i., at very high percentages (Figure 6. B), when mice were 
showing parasitaemias around 62-72% (PbA) or between 20-25% (PbNK65). At this time-point, the 
proportion of G3 is particularly high for PbA in Balb/C mice. However, it is most likely that this increase 
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is due to an increase in multiple infections and not due to an increase in circulating mature blood-
stage forms, since multiple infections would also fall in the G3 gate. 
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Interestingly, a decrease in overall ECM score, was not only observed in PbA-infected C57BL/6 
mice, but also in PbA-infected Balb/C mice and PbNK65-infected C57BL/6 mice. PbA-infected Balb/C 
mice presented with scores as low as 14 and PbNK65-infected mice with scores as low as 15, on 
d6p.i. Though this decrease was not as pronounced as in ECM mice, it was concomitant with the 
decrease in the proportion of circulating G3 in these mice. 
Taken together, these results can suggest that mature schizonts and some late trophozoites of 
PbA and PbN65 may be able to adhere and sequester in some organs, at a certain moment during 
infection. However, we can not exclude that these parasite forms were not seen in circulation due to 
an elimination process mediated by the spleen. In the case of PbA, results suggest that these blood-
stage forms may be those sequestering in the brain during ECM, since their proportion in circulation 
decreases at the onset of the pathology. 
Assessment of PbA cytoadherence in different organs  
One of the possible explanations for the disappearance from circulation of the MF of asexual blood-
stage Plasmodium is their sequestration. To test this hypothesis, C57BL/6 or Balb/C mice were 
infected with PbA expressing a Luciferase-GFP fusion, under the control of the promoter of ama-1 
(PbA-LUCISCHI). Since this protein is expressed only in mature schizonts, only those forms will be 
detected by luminescence.  
The circulating blood-stage forms were followed from d4p.i. onwards, both by observation of 
Giemsa-stained tail-blood smears (for total parasitaemia) and by flow cytometry, to detect the mature 
forms expressing the luciferase-GFP construct. 
Five mice per group were sacrificed at each time point, in a total of 3 time-points. The first time-
point (T1) was on d4pi.i, before the onset of ECM, meaning before schizonts disappear from 
circulation; the second-time point (T2) was at the late stages of ECM for C57BL/6 mice and 24h later 
for Balb/C, when very few schizonts were observed in circulation on all groups; and the third time-point 
(T3) at d14p.i., when mature schizonts are detected again in circulation. Only samples from T1 and T2 
were analysed until this date.  
Our results show for both hosts, at T2, an important sequestration of PbA in the fat tissue (mainly) 
and, at a lesser extent, in the liver (Figure 7. B and D). In the case of C57BL/6 mice, there is also a 
significant increase on the MF remaining in the spleen and the lungs after perfusion, at T2 when 
compared with T1 (Figure 7. A and C). It should be noted that the spleens from Balb/C mice at T2 
were notoriously darker and enlarged. This might indicate higher haemozoin content, though the 
amount of viable schizonts was not significant, which suggests increased parasite elimination by the 
spleen.  
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PbA and PbNK65 cytoadherence capabilities 
As previously shown, both CD8
+
 T cells and PbA accumulate in the brain of C57BL/6 mice during 
ECM, but not in Balb/C mice [14]. Interestingly, PbNK65 infection leads to accumulation of CD8
+
 T 
cells in the brain of C57BL/6 mice, but not to accumulation of pRBCs and does not lead to the 
development of ECM [14]. This was demonstrated by measuring parasite burden in perfused brain 
samples, by quantitative real-time PCR. 
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Brain sections stained with Violet Cresyl were analysed under polarized light to detect haemozoin. 
As expected from previous studies [14], our results clearly show that haemozoin is present in the brain 
of mice during ECM, but not in the brain of PbNK65-infected C57BL/6 mice (Figure 8). Analysis also 
revealed an heterogeneous distribution of haemozoin in the brain of ECM mice. No haemorrhages or 
haemozoin in the brain parenchyma were found in PbNK65-infected brains. 
These results show that mature PbNK65 pRBCs do not accumulate in the brain of C57BL/6 mice, 
since there is no accumulation of haemozoin in this organ. 
 
While PbA accumulates in the brain of C57BL/6 mice, PbNK65 does not [14]. One possible 
explanation that might account for this is that PbNK65 pRBCs don‟t have the inherent capability to 
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adhere to the activated brain microvasculature. To test this hypothesis, two experimental approaches 
were used: an ex vivo (a derivation of the Woodruff-Stamper technique) and an in vivo approach. 
First, brain sections of infected mice were incubated with GFP-expresing pRBCs (see above). 
Whole blood or schizont-enriched blood were used. As a positive control, brain sections from PbA-
infected mice showing signs of ECM were incubated against PbA-GFP infected blood. Since, in vivo, 
PbA pRBCs adhere to the brain microvasculature, if brain tissue and pRBCs maintain their structural 
status, they should also adhere ex vivo.  
Multiple variables were tweaked to attempt optimization of this protocol. These included: duration 
and number of washing steps after incubation with the pRBCs, washing technique, incubation 
with/without rotation, etc. However, in all experiments the positive control didn‟t work properly, i.e. after 
mounting, pRBCs were not found adherent to the brain tissue when analysing the sections under a 
fluorescence microscope (Figure 9). Therefore, no conclusions could be drawn from these 
experiments. 
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A different approach was then attempted, which involved co-infection of C57BL/6 mice with PbA 
and PbNK65-GFP. These “mixed infections” mice were sacrificed at final stages of ECM (ECM score 
below 8) or, in the case of PbNK65-GFP single infection control, 24h later. Relative quantification 
parasites sequestered in the brain was assessed by quantitative real-time PCR of either gfp or 
parasite 18s gene expression. 
Results showed a statistically significant increase in PbNK65 GFP-expressing parasites in the 
brains of “Mixed infections”, comparing with the negative control (mice infected only with PbNK65-
GFP). However, PbA had a much greater contribution for the total parasite burden than PbNK65-GFP 
in these mice (Figure 9), considering that there is a much higher GFP expression in the single PbA-
GFP infection. 
 
It has been described that, in a case of co-infection of PbA and PbNK65, total parasitaemia is 
equivalent to the parasitaemia of each parasite in single infections [55]. In our case, parasitaemias in 
single PbNK65-infections were always lower (Figure 5. A; Annex A: Table 1). In the case of “mixed 
infections”, at the day of sacrifice, PbNK65-GFP accounted only for 9-50% of total parasitaemia. 
Nevertheless, even in the case of the 2 mice that had around 50% of PbNK65-GFP in circulation, the 
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load of this parasite sequestered in the brain is very low when compared to the single PbA-GFP 
infections.  
These results may suggest that PbNK65 pRBCs do not accumulate in the brain of C57BL/6 mice. 
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DISCUSSION AND FUTURE WORK 
In this project our main goal was to study the blood-stage dynamics and sequestration capabilities 
of PbA and PbNK65 in different malaria infection models. To reach this goal, we used GFP- or 
luciferase-expressing parasites to follow blood-stage dynamics.  
As stated above, PbNK65 single-infections showed lower parasitaemias throughout blood-stage 
infection than PbA single-infections. This was more evident in later stages of infection, when 
parasitaemia in the PbNK65 infection was 1/3 of the parasitaemia in the PbA infection (Figure 5. C). 
Though this phenomenon had already been described [56], the causes behind it are still not known. 
By analyzing samples of synchronized pRBCs, we were able to show that PbNK65 can produce only 
half of the number of MPS than PbA. Lower numbers of MPS mean that less new infections are 
generated per cycle, since less merozoites are comparatively released into the bloodstream. This way, 
the parasitaemia growth rate may be lower (reviewed in [23]). This results can be an explanation for 
the lower parasitaemia observed in PbNK65-infected mice. It has been previously described that the 
rate of multiplication strain of PbNK65 strain is the double in mice with increased reticulocytosis [15]. It 
is not yet clear what the factors that influence the number of MPS in each parasite strain are, but the 
size and metabolic state of the host cell likely play a role. PbNK65 has a high affinity for infecting 
reticulocytes, even higher than PbA [15]. Reticulocytes are immature RBCs, still metabolically active 
and larger than normocytes. From the evolutionary perspective, if indeed the size and metabolic 
activity of the host cell play a role in determining the number of MPS, than PbNK65 would gain from 
preferentially infecting these cells. An interesting experiment, to test the hypothesis that host-cell size 
and metabolic state influence the number of MPS, would be evaluating this number in mice with 
increased reticulocytosis versus normal mice. We could induce reticulocytosis in mice before infecting 
with PbNK65-infected blood (by bleeding mice one day prior to infection, or by injecting certain drugs 
that induce this process) and evaluate the number of MPS in reticulocytes versus normocytes. This 
experiment would allow us to make a direct connection between the parasitaemia growth rate and the 
number of MPS. We have tried to perform this experiment, but we weren‟t yet able to increase the 
level of reticulocytes significantly by simply bleeding the mice 24h prior to infection. We would like to 
optimize this protocol in the future, perhaps using phenylhydrazine instead of bleeding the mice. This 
drug is commonly used to induce anaemia in mice, which triggers the production of reticulocytes. 
It should be noted that the duration of the erythrocytic cycle for P. berghei is described as lasting 
between 21 and 24h (reviewed in [15]). However, in our hands this cycle lasted close to 32h. For this, 
we have no explanation, though we can not exclude an interaction between the circadian cycle of the 
host and the circadian cycle of the parasite. 
Concerning the analysis of dynamics of asexual circulating forms, it seems clear that PbA mature 
schizonts and some late trophozoites are nearly absent from circulation from d6-d7p.i. onwards, in 
both the NECM and the ECM model. This can be explained by the possibility that these parasite forms 
are able to adhere and sequester in some organs (other than the brain). Another possibility is that they 
are being eliminated by the spleen, due to the fact that these blood-stage forms are less deformable, 
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larger and have increased expression of surface proteins, rendering them more easily detected by the 
immune system, specifically by splenic macrophages (reviewed in [33]).  
To address the first possibility, we used a PbA line expressing a LUCIFERASE-GFP fusion protein 
in the mature schizonts to infect C57BL/6 mice and Balb/C mice. If our hypothesis was correct and 
these blood-stage forms were being sequestered, we could detect luminescence in certain organs of 
infected mice, after perfusion, and correlate that with the disappearance from circulation. 
Our results suggest that indeed there is sequestration of PbA-schizonts in multiple organs, when 
the proportion of these forms decreases in circulation. In the case of C57BL/6 mice, we confirm 
previously published results [57] that describe sequestration of PbA-schizonts in the spleen, lungs and 
fat tissue. We also detect a small but significant increase in the load of PbA-schizonts in the liver of 
C57BL/6 mice. We also describe here, for the first time, sequestration of PbA-schizonts in Balb/C 
mice, in the fat tissue and the liver. However, there was no significant increase on sequestration of 
viable schizonts in the spleen of these mice, from T1 to T2. However, due to the darker colour and 
bigger size of these spleens, it is probable that there is high haemozoin content. The spleens were 
collected and frozen to quantify haemozoin content (using an haeme detection kit), in the future. This 
should give us an indication if elimination of PbA by the spleen is higher in Balb/C mice. 
In the case of PbA-infected C57BL/6 mice, the proportion of mature stages decreases in circulation 
at the onset of ECM. Concomitant with this, there is also a small but significant decrease in 
parasitaemia (p-value=0,0236; one-tailed Mann-Whitney‟s test) just before the appearance of ECM 
signs, consistent between all experiments. Taking this together with the presence of haemozoin in the 
brain microvasculature of these mice, these results suggest the parasite forms that sequester in the 
brain during ECM are at least in part mature blood-stage forms. This possibility brings this murine 
model of CM and the human pathology even closer together.  
Interestingly, PbNK65 schizonts also appear in low proportions in circulation, from d6p.i. onwards 
in C57BL/6 mice. However, it has been shown that pRBCs don‟t accumulate in the brain during ECM 
[14] (Figure 7). If these parasite forms disappeared from circulation due to sequestration in other 
organs, then the mechanisms responsible for cytoadherence in the brain could be different than those 
responsible for this process in other organs. This has been shown for PbA (reviewed in [57]), so the 
same principle might apply for PbNK65 infection. It would have been interesting to also assess 
sequestration of PbNK65 in C57BL/6 mice, as was done for PbA in Balb/C and C57BL/6 mice. 
However, a different strategy would have to be used since, to date, there is still not a luciferase-
expressing PbNK65 parasite line. The advantage of using a luminescence assay is that this technique 
allows visualization of viable parasites, because it is a protein that is being quantified instead of a 
nucleic acid, which may still be present even if the parasite is already being eliminated. This is more 
problematic when assessing sequestration in the spleen, where the parasite might be going through 
the process of elimination. One possible alternative would be to infect C57BL/6 mice with PbNK65-
GFP and perform a quantitative assay (such as quantitative real time-PCR) to evaluate the presence 
of GFP positive cells in certain organs, compared with the other two models of malaria used in this 
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project. We intend to do this in the near future, by detecting expression of ama-1 instead of expression 
of gfp (to address the fact that this parasite expresses gfp constitutively). 
For PbA as well as PbNK65, the proportion of mature blood-stages has a huge increase in 
circulation in later infection. Two possibilities can explain this. First, it might be a result of saturation in 
the microvasculature, i.e. the organs where mature erythrocytic stages were sequestering are 
saturated and can no longer accumulate more pRBCs. The second hypothesis is that, as the infection 
progresses, the microenvironment inside each organ changes and the “new microenvironment” is no 
longer suitable to promote sequestration.  
Concerning the mechanisms of cytoadherence in the brain, one might argue that the fact that PbA 
adheres in the brain of C57BL/6 mice and not in the brain of Balb/C mice is an indication that the 
mechanisms responsible for cytoadherence are mostly host-related. However, if PbA pRBCs adhere 
in the brain of C57BL/6 mice and PbNK65 pRBCs don‟t, parasite features are probably as important 
as the host is in this process. If cytoadherence of pRBCs to the brain microvasculature is mostly 
dependent on the parasite‟s capability to do so, then in the context of the host-microenvironment of 
PbA infection, PbNK65 still would not be able to adhere to the brain microvasculature. 
To test this hypothesis, our first approach was an ex vivo technique, adapted from a previously 
described protocol, developed by Neres et al. [54] to study pregnancy-associated malaria pathologies. 
In their work, they perform ex vivo cytoadherence assays using placentas from infected and non-
infected female mice incubated with synchronized PbA-GFP infected blood. In our work, PbA-infected 
brain sections were incubated with either PbNK65-GFP or PbA-GFP infected blood. No adherent 
pRBCs were observed in the positive control (PbA-infected brain incubated with PbA-GFP infected 
blood) which doesn‟t allow us to take any conclusions from those experiments.  
There are three possibilities that might explain why this strategy didn‟t work in our case, though it 
was developed for similar models. The first hypothesis is that there is a low probability of finding 
blood-vessels in a single brain section, so the probability of observing cytoadherence of pRBCs is 
greatly reduced. To exclude this possibility, we could also use another organ, as positive control, that 
is more vascularised and for which sequestration is already described, such as the spleen. Another 
hypothesis is that since the brain tissue used was frozen, instead of fresh, perhaps the receptors 
important for cytoadherence in the brain are damaged or have the wrong conformation, so proper 
adherence may not occur. To rule out this possibility, we could use fresh tissue and make sections 
using a vibratome. The third hypothesis is that the process of purifying synchronized pRBCs may 
somehow damage these cells, impairing the cytoadherence process in the brain. Using non-purified 
infected-blood suspensions might allow us to eliminate this possibility. Addressing these hypotheses 
would allow us to understand how we can optimize this protocol. 
In our final approach, we co-infected C57BL/6 mice with PbA and PbNK65-GFP. Since PbA was 
present, the parasite would sequester in the brain and mice would develop ECM. At later stages of 
ECM, we observed a small though significant increase in PbNK65-GFP load in the brain of “mixed 
infections” mice, compared to the negative control (PbNK65-GFP infected mice). However, the GFP 
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load found in the brains of “mixed infections” was likely due to the fact that perfusion in ECM mice is 
less efficient than in NECM mice, since there is vasoconstriction in later stages of ECM. Considering 
this, the GFP load in the brain of “mixed infections” was most probably a residual value. Moreover, 
compared to the PbA-GFP single-infection control, PbNK65-GFP load in the brain of “mixed infections” 
was very low. Briefly, our results suggest that PbNK65 pRBCs do not accumulate in the brain of 
C57BL/6 mice, because they lack the intrinsic capability to do so, and not because the host‟s 
response in the course of infection is not sufficient to generate the appropriate environment for this 
process to occur. 
The present work meant to clarify the dynamics of circulating blood-stage forms in a P. berghei 
infection and how that may correlate with sequestration in multiple organs. Results are not conclusive 
and, as stated during this discussion, more experiments have to be performed to elucidate this matter. 
However, we consider that our findings suggest that sequestration mechanisms in the brain differ from 
those in other organs, in PbA as well as PbNK65. Our results also suggest that PbNK65 pRBCs lack 
of sequestration in the brain of C57BL/6 mice is mainly due to a difference between this strain and the 
PbA strain in terms of intrinsic cytoadherence capability. Moreover, this is the first report of a 
difference in numbers of MPS in PbNK65 infection, which might be an explanation for lower 
parasitaemia growth rates and infectivity that have already been described for this parasite strain.  
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